Æterna Zentaris Inc. (NASDAQ: AEZS) announced that a poster on AEZS-134, a highly potent and selective ATP competitive Erk inhibitor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE